BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9729698)

  • 1. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract]   [Full Text] [Related]  

  • 4. Electroconvulsive therapy-associated Pisa syndrome in clozapine treatment.
    Lee WK; Shiah IS; Chen CY; Lin TL; Shen LJ
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):753. PubMed ID: 19068021
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dystonia: four case histories.
    Yadalam KG; Korn ML; Simpson GM
    J Clin Psychiatry; 1990 Jan; 51(1):17-20. PubMed ID: 1967246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history and treatment of tardive dystonia.
    Kang UJ; Burke RE; Fahn S
    Mov Disord; 1986; 1(3):193-208. PubMed ID: 2904118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic antiparkinsonian drugs in psychiatry.
    Boodhoo JA; Sandler M
    Br J Hosp Med; 1991 Sep; 46(3):167-9. PubMed ID: 1681972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
    Suzuki T; Matsuzaka H
    CNS Drugs; 2002; 16(3):165-74. PubMed ID: 11888337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms for neuroleptic-associated tardive movement disorders.
    Akiyama K
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S23-9. PubMed ID: 10560894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of dystonia].
    Kachi T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1181-2. PubMed ID: 12235832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tardive dystonia--a case report on therapy and metaphylaxis].
    Genz A
    Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tardive dystonia].
    Fujiwara Y; Otani K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):188-92. PubMed ID: 12876962
    [No Abstract]   [Full Text] [Related]  

  • 18. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease.
    Baron MS; Dalton WB
    Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
    Bartels M; Riffel B; Stöhr M
    Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project].
    Mikkelsen VR
    Ugeskr Laeger; 1998 Jul; 160(29):4323-5. PubMed ID: 9679438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.